Our technology

A revolution in drug discovery & development

Drug development is a complex, time-consuming and resource intensive process that often fails to cross the finish line.

Computer assisted drug design (CADD) has long failed to live up to it's promise to streamline that process and deliver truly insightful information to help design better drugs. HTuO's physics-based technology addresses the root of the issue.

Learn More

Our Mission

Unlocking Undruggable Targets in Drug Discovery

From obesity to cancer, seemingly insurmountable medical challenges can be addressed through innovative solutions. However, focusing on seemingly undruggable targets introduces new technical difficulties. At HTuO Biosciences, we have developed a computational solution designed to empower research teams to overcome these challenges across the biopharmaceutical sector. Our mission is to transform challenges into breakthroughs.

About Us
HtuO Bioscience molecule

The HTuO advantage

Introducing high accuracy into modeling gives us and our partners the ability to address the challenges of drug design head-on. A more detailed understanding of how molecules interact allows for data-driven predictions of the best possible drug design - ultimately leading to fewer drugs failing and more efficacious drugs.

Icon discovery
Target Market

Learn more about our potential in the drug discovery & our long term vision.
Applications

Icon discovery
Collaboration

We are happy to discuss any form of a collaboration to let you access our platform.
Partnerships

Icon discovery
Careers

We are always on the lookout for talent. We’re open to fixed location and remote work. See Careers

Team Image

Interested in working with us?

Join the HTuO Team

Check our Careers page for open positions, and see if we have the right opportunity for you.

Open Positions

Recent News & Events

April 7, 2025

HTuO Biosciences will be presenting at Life Science Innovation Northwest 2025, in Seattle, Washington, on April 24, 2025. Find us during the afternoon session, where our CEO, Dr. Anthony Fejes, will talk about our next-gen CADD solution.

October 19, 2024

CEO Anthony Fejes is attending the JLABS Global CEO Summit in New York City. The three-day forum, held exclusively for JLABS company leaders, connects Johnson & Johnson executives, JPALs, dealmakers, entrepreneurs, and investors. The overarching goal of this exclusive event is to help companies bring their sciences and technologies to patients who need them most.

October 9, 2024

Our Director of Business Development, Mr. Jacek Mis, will be in Stockholm, Sweden, Nov 3-6 at the 2024 BIO-Europe. Connect with Jacek through the partnering portal or email us directly to learn about HTuO and our drug discovery goals.

View All News & Events